DNA methylation in the pathogenesis of type 2 diabetes
Related Experiment Video
Updated: Aug 8, 2025

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
Suneesh Kaimala1, Suraiya Anjum Ansari2, Bright Starling Emerald3
1Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, United Arab Emirates.
Abstract:
Type 2 diabetes (T2D) is a metabolic disease characterized by the development of β-cell dysfunction with hepatic, muscular and adipose tissue insulin resistance. Although the molecular mechanisms leading to its development are not entirely known, investigations of its causes reveal a multifactorial contribution to its development and progression in most cases. In addition, regulatory interactions mediated by epigenetic modifications such as DNA methylation, histone tail modifications and regulatory RNAs have been found to play a significant role in the etiology of T2D. In this chapter, we discuss the role of DNA methylation and its dynamics in the development of the pathological features of T2D.
Insights
This chapter explores how DNA methylation, an epigenetic factor, contributes to the development of type 2 diabetes (T2D). Understanding these molecular changes is key to addressing this complex metabolic disease.
Area of Science:
- Epigenetics
- Molecular Biology
- Metabolic Diseases
Background:
- Type 2 diabetes (T2D) involves beta-cell dysfunction and insulin resistance in multiple tissues.
- The exact molecular mechanisms of T2D are complex and multifactorial.
- Epigenetic modifications, including DNA methylation, are implicated in T2D's etiology.
Purpose of the Study:
- To discuss the role of DNA methylation in T2D development.
- To examine the dynamics of DNA methylation in pathological T2D features.
Main Methods:
- Review of current literature on DNA methylation and T2D.
- Analysis of epigenetic regulatory interactions.
Main Results:
- DNA methylation plays a significant role in the development of T2D.
- Dynamic changes in DNA methylation are linked to T2D pathology.
Conclusions:
- DNA methylation is a critical epigenetic factor in T2D pathogenesis.
- Further research into DNA methylation dynamics may reveal therapeutic targets for T2D.
More Related Videos
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Epigenetic Regulation
Diabetes: Symptoms, Diagnosis, and Complications